Jacob Waldrop
Vermogen: 575 053 $ op 30-06-2026
Vermogen: 575 053 $ op 30-06-2026
Jacob A. Waldrop is Chief Operating Officer at Sanara MedTech, Inc. since 2024.
Formerly, Mr. Waldrop was Chief Financial Officer at Trilliant Surgical LLC and Vice President-Finance & Integrations at Enovis Corp.
Mr. Waldrop completed undergraduate studies at Texas A&M University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SANARA MEDTECH, INC. 0,27% | 15-04-2026 | 24.377 ( 0,27% ) | 575 053 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| SANARA MEDTECH INC. | Operationeel Directeur | 15-04-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
Trilliant Surgical LLC
Trilliant Surgical LLC Medical SpecialtiesHealth Technology Designs, develops, manufactures and distributes small bone podiatric implants | Financieel Directeur/CFO | - |
| ENOVIS CORPORATION | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Sanara MedTech, Inc.
Sanara MedTech, Inc. Medical SpecialtiesHealth Technology Provides medical products, advanced biotechnology solutions and applications | Health Technology |
Enovis Corp.
Enovis Corp. Medical SpecialtiesHealth Technology Develops, manufactures and supplies medical devices used for reconstructive surgery, rehabilitation, pain management and physical therapy | Health Technology |
Texas A&M University
Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trilliant Surgical LLC
Trilliant Surgical LLC Medical SpecialtiesHealth Technology Designs, develops, manufactures and distributes small bone podiatric implants | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau